Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuying Qiu

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Psychiatry Investigation|October 5, 2023
Identification of Plasma Biomarkers in Drug-Naïve Schizophrenia Using Targeted MetabolomicsQiao Su, Fuyou Bi, Shu Yang, et al.
Clinical Rheumatology|November 5, 2022
An observational study of clinical recurrence in patients with interstitial lung disease related to the antisynthetase syndromeHaoran Chen, Huarui Liu, Wenting Lyu, et al.
BMC Psychiatry|May 13, 2024
Targeted metabolomics-based understanding of the sleep disturbances in drug-naïve patients with schizophreniaHuiming Yan, Gang Li, Xue Zhang, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 25, 2023
Negative symptoms and neurocognition in drug-naïve schizophrenia: moderating role of plasma neutrophil gelatinase-associated lipocalin (NGAL) and interferon-gamma (INF-γ)Meijuan Li, Guoshuai Luo, Yuying Qiu, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 8, 2026
Association between thyroid hormone T3 and aggression in drug-naïve schizophrenia: a directed acyclic graph analysisCong Yao, Changyong Jiang, Meng Zhang, et al.
Psychiatry Research|June 28, 2025
The relationship between inflammation and cognitive function in drug-naïve schizophrenia with or without pre-metabolic syndromeQiao Su, Jiayue Wang, Hongmin Ge, et al.
BMC Psychiatry|June 11, 2026
Association between serum non-enzymatic antioxidants and cognitive impairment in drug-naïve patients with schizophreniaZhenning Feng, Yuying Qiu, Yanyan Wang, et al.
Cytokine & Growth Factor Reviews|May 4, 2020
Cytokine storm intervention in the early stages of COVID-19 pneumoniaXinjuan Sun, Tianyuan Wang, Dayong Cai, et al.
Clinical and Experimental Rheumatology|February 24, 2023
Increased serum levels of sCD40L were associated with rapidly progressive interstitial lung disease in idiopathic inflammatory myopathiesWenting Lyu, Wanqing Zhou, Qingqing Xu, et al.
Rheumatology (Oxford, England)|January 27, 2021
Cytokeratin 19 fragment is associated with severity and poor prognosis of interstitial lung disease in anti-MDA5 antibody-positive dermatomyositisXianhua Gui, Miao Ma, Jingjing Ding, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Psychiatry Investigation|October 5, 2023
Identification of Plasma Biomarkers in Drug-Naïve Schizophrenia Using Targeted MetabolomicsQiao Su, Fuyou Bi, Shu Yang, et al.
Clinical Rheumatology|November 5, 2022
An observational study of clinical recurrence in patients with interstitial lung disease related to the antisynthetase syndromeHaoran Chen, Huarui Liu, Wenting Lyu, et al.
BMC Psychiatry|May 13, 2024
Targeted metabolomics-based understanding of the sleep disturbances in drug-naïve patients with schizophreniaHuiming Yan, Gang Li, Xue Zhang, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 25, 2023
Negative symptoms and neurocognition in drug-naïve schizophrenia: moderating role of plasma neutrophil gelatinase-associated lipocalin (NGAL) and interferon-gamma (INF-γ)Meijuan Li, Guoshuai Luo, Yuying Qiu, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 8, 2026
Association between thyroid hormone T3 and aggression in drug-naïve schizophrenia: a directed acyclic graph analysisCong Yao, Changyong Jiang, Meng Zhang, et al.
Psychiatry Research|June 28, 2025
The relationship between inflammation and cognitive function in drug-naïve schizophrenia with or without pre-metabolic syndromeQiao Su, Jiayue Wang, Hongmin Ge, et al.
BMC Psychiatry|June 11, 2026
Association between serum non-enzymatic antioxidants and cognitive impairment in drug-naïve patients with schizophreniaZhenning Feng, Yuying Qiu, Yanyan Wang, et al.
Cytokine & Growth Factor Reviews|May 4, 2020
Cytokine storm intervention in the early stages of COVID-19 pneumoniaXinjuan Sun, Tianyuan Wang, Dayong Cai, et al.
Clinical and Experimental Rheumatology|February 24, 2023
Increased serum levels of sCD40L were associated with rapidly progressive interstitial lung disease in idiopathic inflammatory myopathiesWenting Lyu, Wanqing Zhou, Qingqing Xu, et al.
Rheumatology (Oxford, England)|January 27, 2021
Cytokeratin 19 fragment is associated with severity and poor prognosis of interstitial lung disease in anti-MDA5 antibody-positive dermatomyositisXianhua Gui, Miao Ma, Jingjing Ding, et al.
Pageof 6